Table 4-.
Cases | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Variant status | Gene | Position | rs ID | Number of DLB Cases | AF in DLB Cases (n=2530) | AF(AAC)-DLB (n=0) | AF(AMR)-DLB (n=0) | AF(FIN)-DLB (n=5) | AF(CAS)-DLB (n=0) | AF(MDE)-DLB (n=6) | AF(AFR)-DLB (n=0) | AF(EAS)-DLB (n=0) | AF(AJ)-DLB (n=113) | AF(SAS)-DLB (n=0) | AF(EUR)-DLB (n=2406) | AF(CAH)-DLB (n=0) |
AoU | ||||||||||||||||
Known | APP | chr21: 25891796:C:T | rs63750066 | 1 | 1.98E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.08E-04 | 0 |
Novel | MAPT | chr17:46024088:G:A | rs768841567 | 1 | 1.98E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.08E-04 | 0 |
UKB | ||||||||||||||||
Novel | GRN | chr17:44352395:G:A | rs886053006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Known | GRN | chr17:44352404:C:T | rs63751294 | 1 | 1.98E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.08E-04 | 0 |
Novel | APP | chr21:25905048:C:T | rs368159818 | 1 | 1.98E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.08E-04 | 0 |
Controls | ||||||||||||||||
Variant status | Gene | Position | rs ID | Number of Controls | AF in Controls (n=3270) | AF(AAC)-Controls (n=40) | AF(AMR)-Controls (n=14) | AF(FIN)-Controls (n=5) | AF(CAS)-Controls (n=3) | AF(MDE)-Controls (n=4) | AF(AFR)-Controls (n=29) | AF(EAS)-Controls (n=5) | AF(AJ)-Controls (n=246) | AF(SAS)-Controls (n=1) | AF(EUR)-Controls (n=2919) | AF(CAH)-Controls (n=4) |
AoU | ||||||||||||||||
Known | APP | chr21: 25891796:C:T | rs63750066 | 1 | 1.53E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.71E-04 | 0 |
Novel | MAPT | chr17:46024088:G:A | rs768841567 | 1 | 1.53E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.71E-04 | 0 |
UKB | ||||||||||||||||
Novel | GRN | chr17:44352395:G:A | rs886053006 | 1 | 1.53E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.71E-04 | 0 |
Known | GRN | chr17:44352404:C:T | rs63751294 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Novel | APP | chr21:25905048:C:T | rs368159818 | 1 | 1.53E-04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.71E-04 | 0 |
Key: UKB, UK Biobank; AMP PD, Accelerating Medicines Partnership in Parkinson’s Disease ; AoU, All of Us; Position refers to GRCh 38.